Press releases
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Edwards Lifesciences Reports Fourth Quarter Results
More ▼
Key statistics
As of last trade Edwards Lifesciences Corp (EWL:BER) traded at 78.92, -10.38% below its 52-week high of 88.06, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 78.92 |
---|---|
High | 78.92 |
Low | 78.92 |
Bid | 78.95 |
Offer | 79.20 |
Previous close | 79.31 |
Average volume | 285.29 |
---|---|
Shares outstanding | 602.60m |
Free float | 597.24m |
P/E (TTM) | 36.64 |
Market cap | 51.37bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of May 06 2024 07:08 BST.
More ▼